Insider: Beskrovnaya Oxana Chief Scientific Officer - Dyne Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 195,840 | 0 | 195,840 |
| Value | $2,463,667.20 | $0.00 | $2,463,667.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2025 | DDS | 2,153 | Direct | COM | $11.38 | $24,501.14 | 195,840 |
| 03/05/2025 | DDS | 1,094 | Direct | COM | $11.83 | $12,942.02 | 197,993 |
| 02/18/2025 | DDS | 2,598 | Direct | COM | $13.95 | $36,242.10 | 199,087 |
| 12/11/2024 | DDS | 2,334 | Direct | COM | $28.12 | $65,632.08 | 201,685 |
| 11/18/2024 | DDS | 2,856 | Direct | COM | $28.20 | $80,539.20 | 137,519 |
| 09/18/2024 | DDS | 2,339 | Direct | COM | $34.55 | $80,812.45 | 140,375 |
| 09/11/2024 | DDS | 2,161 | Direct | COM | $31.89 | $68,914.29 | 142,714 |
| 08/19/2024 | DDS | 2,340 | Direct | COM | $45.01 | $105,323.40 | 145,171 |
| 08/19/2024 | DDS | 296 | Direct | COM | $46.00 | $13,616.00 | 144,875 |
| 06/11/2024 | DDS | 2,136 | Direct | COM | $31.34 | $66,942.24 | 147,511 |
| 05/20/2024 | DDS | 12,147 | Direct | COM | $33.51 | $407,045.97 | 150,792 |
| 05/20/2024 | DDS | 17,134 | Direct | COM | $32.49 | $556,683.66 | 162,939 |
| 05/20/2024 | DDS | 1,145 | Direct | COM | $34.08 | $39,021.60 | 149,647 |
| 05/16/2024 | DDS | 2,222 | Direct | COM | $28.20 | $62,660.40 | 150,130 |
| 05/16/2024 | DDS | 483 | Direct | COM | $28.59 | $13,808.97 | 149,647 |
| 03/11/2024 | DDS | 2,081 | Direct | COM | $25.70 | $53,481.70 | 152,352 |
| 03/07/2024 | DDS | 2,373 | Direct | COM | $25.85 | $61,342.05 | 154,433 |
| 12/11/2023 | DDS | 1,467 | Direct | COM | $10.72 | $15,726.24 | 176,585 |
| 09/18/2023 | DDS | 1,436 | Direct | COM | $9.41 | $13,512.76 | 84,334 |
| 09/12/2023 | DDS | 1,484 | Direct | COM | $10.41 | $15,448.44 | 85,770 |
| 06/13/2023 | DDS | 1,475 | Direct | COM | $12.43 | $18,334.25 | 87,254 |
| 03/14/2023 | DDS | 1,416 | Direct | COM | $13.33 | $18,875.28 | 88,729 |
| 12/12/2022 | DDS | 680 | Direct | COM | $10.87 | $7,391.60 | 90,145 |
| 03/11/2022 | DDS | 693 | Direct | COM | $8.73 | $6,049.89 | 53,676 |
| 09/21/2021 | DDS | 827 | Direct | COM | $16.11 | $13,322.97 | 17,845 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research